Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells

Virology Journal

Volumn 7, Issue , 2010, Pages

  Gourzones, Claire ^a   Gelin, Aurore ^a   Bombik, Izabela ^a   Klibi, Jihène ^a   Vérillaud, Benjamin ^a   Guigay, Jol ^a   Lang, Philippe ^c   Témam, Stéphane ^a   Schneider, Véronique ^b   Amiel, Corinne ^b   Baconnais, Sonia ^a   Jimenez, Anne Sophie ^a   Busson, Pierre ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BAM H1 A RIGHTWARD TRANSCRIPT MICRORNA; MICRORNA; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CANCER MODEL; CANCER PATIENT; CARCINOMA CELL; CONTROLLED STUDY; EPSTEIN BARR VIRUS INFECTION; EXOSOME; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR STABILITY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TUMOR XENOGRAFT; ADULT; AGED; ANIMAL; BLOOD; CHEMISTRY; EPSTEIN BARR VIRUS; FEMALE; MALE; METABOLISM; MIDDLE AGED; NASOPHARYNX TUMOR; NUDE MOUSE; PATHOGENICITY; VIROLOGY; XENOGRAFT;

HUMAN HERPESVIRUS 4; MUS MUSCULUS;

ADULT; AGED; ANIMALS; EXOSOMES; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MICE; MICE, NUDE; MICRORNAS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TRANSPLANTATION, HETEROLOGOUS;

EID: 77957904197     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-271     Document Type: Article

References (33)

1. Descriptive, environmental and genetic epidemiology of nasopharyngeal carcinoma. http://www.landesbioscience.com/curie/chapter/4601/
2. EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies. P Busson C Keryer T Ooka M Corbex, Trends Microbiol 2004 12 356 360 10.1016/j.tim.2004.06.005 15276610
3. Identification of virus-encoded microRNAs. S Pfeffer M Zavolan FA Grasser M Chien JJ Russo J Ju B John AJ Enright D Marks C Sander T Tuschl, Science 2004 304 734 736 10.1126/science.1096781 15118162
4. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. X Cai A Schafer S Lu JP Bilello RC Desrosiers R Edwards N Raab-Traub BR Cullen, PLoS Pathog 2006 2 23 10.1371/journal.ppat. 0020023 16557291
5. MicroRNAs as potential cancer therapeutics. P Trang JB Weidhaas FJ Slack, Oncogene 2008 27 2 52 57 10.1038/onc.2009.353 19956180
6. Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs. O Rechavi Y Erlich H Amram L Flomenblit FV Karginov I Goldstein GJ Hannon Y Kloog, Genes Dev 2009 23 1971 1979 10.1101/gad.1789609 19684116
7. Functional delivery of viral miRNAs via exosomes. DM Pegtel K Cosmopoulos DA Thorley-Lawson MA van Eijndhoven ES Hopmans JL Lindenberg TD de Gruijl T Wurdinger JM Middeldorp, Proc Natl Acad Sci USA 2010 107 6328 6333 10.1073/pnas.0914843107 20304794
8. Secretory mechanisms and intercellular transfer of microRNAs in living cells. N Kosaka H Iguchi Y Yoshioka F Takeshita Y Matsuki T Ochiya, J Biol Chem 2010 285 17442 17452 10.1074/jbc.M110.107821 20353945
9. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. DJ Gibbings C Ciaudo M Erhardt O Voinnet, Nat Cell Biol 2009 11 1143 1149 10.1038/ncb1929 19684575
10. Export of microRNAs and microRNA-protective protein by mammalian cells. K Wang S Zhang J Weber D Baxter DJ Galas, Nucleic Acids Res 2010
11. Exosome function: from tumor immunology to pathogen biology. JS Schorey S Bhatnagar, Traffic 2008 9 871 881 10.1111/j.1600-0854.2008.00734.x 18331451
12. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. DD Taylor C Gercel-Taylor, Gynecol Oncol 2008 110 13 21 10.1016/j.ygyno.2008.04.033 18589210
13. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. J Skog T Wurdinger S van Rijn DH Meijer L Gainche M Sena-Esteves WT Curry Jr BS Carter AM Krichevsky XO Breakefield, Nat Cell Biol 2008 10 1470 1476 10.1038/ncb1800 19011622
14. Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. RH Edwards AR Marquitz N Raab-Traub, J Virol 2008 82 9094 9106 10.1128/JVI.00785-08 18614630
15. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. K Cosmopoulos M Pegtel J Hawkins H Moffett C Novina J Middeldorp DA Thorley-Lawson, J Virol 2009 83 2357 2367 10.1128/JVI.02104-08 19091858
16. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. JY Zhu T Pfuhl N Motsch S Barth J Nicholls F Grasser G Meister, J Virol 2009 83 3333 3341 10.1128/JVI.01689-08 19144710
17. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. ZL Pratt M Kuzembayeva S Sengupta B Sugden, Virology 2009 386 387 397 10.1016/j.virol.2009.01.006 19217135
18. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. SJ Chen GH Chen YH Chen CY Liu KP Chang YS Chang HC Chen, PLoS One 5
19. EBV gene expression in an NPC-related tumour. MM Hitt MJ Allday T Hara L Karran MD Jones P Busson T Tursz I Ernberg BE Griffin, Embo J 1989 8 2639 2651 2479554
20. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. H Valadi K Ekstrom A Bossios M Sjostrand JJ Lee JO Lotvall, Nat Cell Biol 2007 9 654 659 10.1038/ncb1596 17486113
21. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. J Klibi T Niki A Riedel C Pioche-Durieu S Souquere E Rubinstein SL Moulec J Guigay M Hirashima F Guemira,, et al. Blood 2009 113 1957 1966 10.1182/blood-2008-02-142596 19005181
22. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Z Lu M Liu V Stribinskis CM Klinge KS Ramos NH Colburn Y Li, Oncogene 2008 27 4373 4379 10.1038/onc.2008.72 18372920
23. Circulating microRNAs as stable blood-based markers for cancer detection. PS Mitchell RK Parkin EM Kroh BR Fritz SK Wyman EL Pogosova-Agadjanyan A Peterson J Noteboom KC O'Briant A Allen,, et al. Proc Natl Acad Sci USA 2008 105 10513 10518 10.1073/pnas.0804549105 18663219
24. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. KJ Gilligan P Rajadurai JC Lin P Busson M Abdel-Hamid U Prasad T Tursz N Raab-Traub, J Virol 1991 65 6252 6259 1656092
25. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. P Busson G Ganem P Flores F Mugneret B Clausse B Caillou K Braham H Wakasugi M Lipinski T Tursz, Int J Cancer 1988 42 599 606 10.1002/ijc.2910420422 2971626
26. Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. G Obernosterer J Martinez M Alenius, Nat Protoc 2007 2 1508 1514 10.1038/nprot.2007.153 17571058
27. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. EY Choy KL Siu KH Kok RW Lung CM Tsang KF To DL Kwong SW Tsao DY Jin, J Exp Med 2008 205 2551 2560 10.1084/jem.20072581 18838543
28. Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation. F Sbih-Lammali B Clausse H Ardila-Osorio R Guerry M Talbot S Havouis L Ferradini J Bosq T Tursz P Busson, Cancer Res 1999 59 924 930 10029086
29. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. ST Cheung DP Huang AB Hui KW Lo CW Ko YS Tsang N Wong BM Whitney JC Lee, Int J Cancer 1999 83 121 126 10.1002/(SICI)1097-0215(19990924) 83:1<121::AID-IJC21>3.0.CO;2-F 10449618
30. Production and characterization of clinical grade exosomes derived from dendritic cells. HG Lamparski A Metha-Damani JY Yao S Patel DH Hsu C Ruegg JB Le Pecq, J Immunol Methods 2002 270 211 226 12379326
31. Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. AT Chan E Felip, Ann Oncol 2009 20 4 123 125 10.1093/annonc/mdp150 19454431
32. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. A Dehee C Asselot T Piolot C Jacomet W Rozenbaum M Vidaud A Garbarg-Chenon JC Nicolas, J Med Virol 2001 65 543 552 10.1002/jmv.2071 11596092
33. Real-time quantification of microRNAs by stem-loop RT-PCR. C Chen DA Ridzon AJ Broomer Z Zhou DH Lee JT Nguyen M Barbisin NL Xu VR Mahuvakar MR Andersen,, et al. Nucleic Acids Res 2005 33 179 10.1093/nar/gni178 16314309